News + Filings Transactions
|
White William Richard
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 606 | $55.16 | $33.4k | | 06/13/2023 |
| 06/09/2023 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 7.1k | $45.69 | $326k | | 06/09/2023 |
| 06/08/2023 | Ventyx Biosciences, Inc. | | Grant | Stock Option (Right to Buy) | 15.9k | $34.83 | $555.1k | | 06/08/2023 |
| 03/10/2023 | Akero Therapeutics, Inc. | AKRO | Payment of Exercise | Common Stock | 641 | $43.47 | $27.9k | | 03/10/2023 |
| 01/23/2023 | Ventyx Biosciences, Inc. | | Sale | Common Stock | 5k | $34.33 | $173.3k | | 01/23/2023 |
| 01/23/2023 | Ventyx Biosciences, Inc. | | Sale | Common Stock | 21.3k | $35.01 | $745k | | 01/23/2023 |
| 01/23/2023 | Ventyx Biosciences, Inc. | | Sale | Common Stock | 7k | $35.91 | $252.3k | | 01/23/2023 |
| 01/23/2023 | Ventyx Biosciences, Inc. | | Exercise | Stock Option (Right to Buy) | 33.4k | $6.03 | $201.1k | | 01/23/2023 |
| 12/29/2022 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 7k | $13.50 | $94.5k | | 12/29/2022 |
| 12/28/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 999 | $49.76 | $49.7k | | 12/27/2022 |
| 12/28/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 999 | $7.01 | $7k | | 12/27/2022 |
| 12/27/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 19k | $7.01 | $133.2k | | 12/27/2022 |
| 12/27/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 19k | $49.77 | $945.6k | | 12/27/2022 |
| 12/16/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.4k | | 12/16/2022 |
| 12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 19.2k | $0.00 | $0 | | 12/09/2022 |
| 12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 86.4k | $42.95 | $3.7M | | 12/09/2022 |
| 10/13/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 20k | $7.01 | $140.2k | | 10/13/2022 |
| 10/13/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 20k | $39.82 | $796.4k | | 10/13/2022 |
| 09/13/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 18.9k | $26.42 | $499.9k | | 09/13/2022 |
| 09/13/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 13.6k | $27.87 | $378.5k | | 09/13/2022 |
| 09/13/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 32.5k | $7.01 | $227.8k | | 09/13/2022 |
| 09/13/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
| 09/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
| 06/30/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1.2k | $8.03 | $9.3k | | 09/09/2022 |
| 06/09/2022 | Ventyx Biosciences, Inc. | | Grant | Stock Option (right to buy) | 13.3k | $16.54 | $220k | | 06/09/2022 |
| 01/14/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 9.7k | $22.03 | $213.7k | | 01/14/2022 |
| 01/14/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 9.7k | $7.01 | $68k | | 01/14/2022 |
| 12/21/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 100 | $22.00 | $2.2k | | 12/21/2021 |
| 12/21/2021 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 100 | $7.01 | $700.9 | | 12/21/2021 |
| 12/17/2021 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 3.2k | $7.01 | $22.4k | | 12/17/2021 |
| 12/17/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.2k | $22.04 | $70.5k | | 12/17/2021 |
| 12/08/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 87.2k | $21.10 | $1.8M | | 12/08/2021 |
| 11/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 6.5k | $22.24 | $144.6k | | 11/01/2021 |
| 11/01/2021 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 6.5k | $7.01 | $45.6k | | 11/01/2021 |
| 10/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 6.5k | $22.06 | $143.4k | | 10/01/2021 |
|
|